Texas · Nonprofit
Gencure
Gencure (Texas) receives grants from 6 organizations whose IRS filings report $1,350,486 to it, the largest being THE BLOOD & TISSUE CENTER FOUNDATION ($1,052,986). 3 of them have funded it in more than one year.
- Revenue FY2024
- $5.4M
- Funders on record
- 6
- Grants received
- $1.4M
- Net assets
- $-2719021
What Gencure does
Mission
Gencure is organized to focus on regenerative medicine and the utilization of the power of human cells and tissue to enhance lives and enable clinical advancements.
As stated on its FY2024 Form 990.
Program
During the reporting year, the organization advanced its enterprise-wide quality and operational infrastructure through several key initiatives. The ISO 9001:2015 certification was successfully renewed and extended to the GenCure site, reinforcing alignment across the Quality Management System and ensuring consistent standards across manufacturing, testing, and clinical operations. A full GMP compliance audit was also completed, verifying adherence to FDA regulations and confirming cGMP readiness across bioproduction and testing facilities. The organization also advanced its quality assurance framework through successful execution of process validation and system qualification activities. These efforts ensured that critical production and testing systems operate consistently within defined parameters, supporting product integrity and regulatory compliance. By validating key processes and qualifying (Continued on Schedule O)
$11,074,605 spent$5,427,037 earned by the program100% of program spending
The program described on its FY2024 Form 990. Program spending in total: $11,074,605.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2018 to 2019, from $17M to $27M (+54%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
0% of Gencure’s revenue is contributions — more earned-revenue than three-quarters of its peers (51% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 8 of the last 8 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Chief executive
Rogelio Zamilpa
Executive Director, Biomanufacturing & Collab
As listed on its FY2024 Form 990.
The chief executive listed changed between the FY2018 and FY2019 filings.
Who funds it, year by year
2017 → 2020: the base broadened from 1 funder to 3 funders, grant income rose $153k → $263k.
From the IRS filings of Gencure’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
Gencure leans on a few funders — its largest provides 78% of grant income and the top three 98%; half comes from just 1 funder.
the vertical line marks half of all grant income — 1 funder to its left
98% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund Gencure.
Largest funder’s share by year: 2017 100% · 2018 52% · 2019 97% · 2020 93% — diversifying over time.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
100% of Gencure's grant income comes from Texas funders.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
Gencure's funding base is broadening — from 1 funders to 3 as grant income climbed.
this organization peer median middle 50% of peers· 8,121 health nonprofits $1M–$10M, FY2024
Organizations like Gencure
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Texas
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
69% of spending goes to programs.
Governance
Public support
100%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Part of a family of 5 related entities
- South Texas Blood & Tissue Center · exempt
- The Blood & Tissue Center Foundation · exempt
- Biobridge Global · exempt
- Qualtex Laboratories · exempt
- Helping Hearts Fund · exempt
Screen this organization
A dated, signed PDF of the compliance screen for Gencure: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds Gencure?
- Gencure (Texas) receives grants from 6 organizations whose IRS filings report $1,350,486 to it, the largest being THE BLOOD & TISSUE CENTER FOUNDATION ($1,052,986). 3 of them have funded it in more than one year.
- How many funders does Gencure have?
- IRS filings report 6 organizations giving $1,350,486 in grants to Gencure, 3 of which have funded it in more than one year.
- Who is the largest funder of Gencure?
- THE BLOOD & TISSUE CENTER FOUNDATION is the largest funder on record, with $1,052,986 in grants. The full list of funders is on this page.
- How can an organization like Gencure find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Texas. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 6 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing